CorMedix (CRMD) Change in Receivables (2015 - 2025)

CorMedix has disclosed Change in Receivables across 10 years of filings, most recently posting $12.4 million for Q4 2025.

• Change in Receivables for Q4 2025 came in at $12.4 million, down 63.97% year-over-year; the trailing twelve-month figure through Dec 2025 was $90.9 million (up 76.26% YoY), and the FY2025 annual result was $90.9 million, up 75.56% from the prior year.
• Change in Receivables came in at $12.4 million for Q4 2025 at CorMedix, down from $87.3 million in the prior quarter.
• In the past five years, Change in Receivables ranged from a high of $87.3 million in Q3 2025 to a low of -$11.7 million in Q2 2025.
• The 4-year median for Change in Receivables is $21337.0 (2021), against an average of $10.2 million.
• Peak annual rise in Change in Receivables reached 1825.73% in 2021, while the deepest fall reached 1290.7% in 2021.
• CorMedix's Change in Receivables stood at $47354.0 in 2021, then slumped by 99.07% to $440.0 in 2022, then jumped by 7818889.55% to $34.4 million in 2024, then plunged by 63.97% to $12.4 million in 2025.
• The last three Change in Receivables figures came in at $12.4 million (Q4 2025), $87.3 million (Q3 2025), and -$11.7 million (Q2 2025), per Business Quant data.